National Medical Products Administration(NMPA) of China releases two guidances on drug registration categories for Chemical Drugs / Biologic Products and Requirements for submission:-
a) 化学药品注册分类及申报资料要求 Classification System for Registration of Chemical
read more...Therapeutic Goods Administration(TGA) of Australia will adopt the current version of the PIC/S Guide to Good Manufacturing Practice for Medicinal Products PE009-14 (PIC/S Guide to GMP), excluding Annexes 4, 5
read more...03 June 2020, The Ministry of Health, Labour and Welfare (MHLW) of Japan released a document providing general guidelines for the clinical evaluation of children that can also be evaluated
read more...On June 2020, Medical Device Authority (MDA) of Malaysia has published a guidance document to set a framework for the management of medical device distribution records.
The guidance document is created
read more...Taiwan Food and Drug Administration (FDA) published a guideline on 28 May 2020 to improve the efficiency of new drug reviews and strengthen the link between Good Clinical Practice (hereinafter
read more...Towards an aim to ensure the quality and data management of bioequivalence study, the Taiwan Food and Drug Administration ( FDA ) intends to conduct the inspection from the year,
read more...Upon the review and approval of the plenary meeting of 11th Pharmacopoeia Commission Executive Committee, China’s National Medical Products Administration (NMPA) and National Healthcare Commission (NHC) have jointly released the
read more...On 29 May 2020, the National Medical Products Administration ( NMPA) of China has formulated a “Guiding Principles for On-site Inspection of Independent Software for Medical Device Production Quality Management
read more...The National Medical Products Administration (NMPA) of China has released a circular as a guiding principle for the preservation of essential documents for Drug Clinical Trials. The Guideline has been
read more...